Stock data
Avita Medical, Inc. (RCEL)
Avita Medical, Inc. (RCEL) reported revenue of US$71.61M and net income of -US$48.59M for fiscal 2025. The figures below come from the company's SEC filings.
Annual results
Data as of 2025-12-31
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | US$71.61M | US$58.82M | -US$42.53M | -US$48.59M | — |
| 2024 | US$64.25M | US$55.16M | -US$56.59M | -US$61.84M | — |
| 2023 | US$50.14M | US$42.36M | -US$42.66M | -US$35.38M | — |
| 2022 | US$34.42M | US$28.38M | -US$27.50M | -US$26.66M | — |
| 2021 | US$29.23M | US$23.28M | -US$26.54M | -US$26.58M | — |
Quarterly results
Data as of 2026-06-30
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-06-30 | US$21.70M | -US$7.66M | — |
| 2026-03-31 | US$19.25M | -US$10.61M | — |
| 2025-12-31 | US$17.62M | -US$11.62M | — |
| 2025-09-30 | US$17.06M | -US$13.19M | — |
| 2025-06-30 | US$18.42M | -US$9.92M | — |
| 2025-03-31 | US$18.51M | -US$13.86M | — |
| 2024-12-31 | US$18.41M | -US$11.59M | — |
| 2024-09-30 | US$19.55M | -US$16.20M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.